GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.030
-0.120 (-5.58%)
At close: May 15, 2026, 4:00 PM EDT
2.100
+0.070 (3.45%)
After-hours: May 15, 2026, 7:08 PM EDT
GRI Bio Employees
GRI Bio had 4 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,727,000
Market Cap
2.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - | 3 | 1 |
| Dec 31, 2024 | 4 | 0 | - | 3 | 1 |
| Dec 31, 2023 | 4 | 3 | 300.00% | 4 | 0 |
| Dec 31, 2022 | 1 | - | - | 1 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 19 |
| GeoVax Labs | 19 |
| Azitra | 13 |
| Ensysce Biosciences | 10 |
| Revelation Biosciences | 9 |
| Indaptus Therapeutics | 5 |
GRI News
- 3 days ago - GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline - GlobeNewsWire
- 5 weeks ago - GRI Bio receives UAE patent allowance for inflammatory disease treatments - TheFly
- 5 weeks ago - GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions - GlobeNewsWire
- 3 months ago - GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment - GlobeNewsWire
- 3 months ago - GRI Bio Transcript: Corporate Connect Webinar Series - Transcripts
- 3 months ago - GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial - GlobeNewsWire
- 3 months ago - GRI Bio sees cash runway into 1Q27 - TheFly
- 3 months ago - GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights - GlobeNewsWire